Literature DB >> 25521639

Hypothermic machine preservation facilitates successful transplantation of "orphan" extended criteria donor livers.

J V Guarrera1, S D Henry, B Samstein, E Reznik, C Musat, T I Lukose, L E Ratner, R S Brown, T Kato, J C Emond.   

Abstract

Hypothermic machine preservation (HMP) remains investigational in clinical liver transplantation. It is widely used to preserve kidneys for transplantation with improved results over static cold storage (SCS). At our center, we have used HMP in 31 adults receiving extended criteria donor (ECD) livers declined by the originating United Network for Organ Sharing region ("orphan livers"). These cases were compared to ECD SCS cases in a matched cohort study design. Livers were matched for donor age, recipient age, cold ischemic time, donor risk index and Model for End-Stage Liver Disease (MELD) score. HMP was performed for 3-7 h at 4-8 °C using our previously published protocol. Early allograft dysfunction rates were 19% in the HMP group versus 30% in the control group (p = 0.384). One-year patient survival was 84% in the HMP group versus 80% in the SCS group (p = NS). Post hoc analysis revealed significantly less biliary complications in the HMP group versus the SCS group (4 vs. 13, p = 0.016). Mean hospital stay was significantly shorter in the HMP group (13.64 ± 10.9 vs. 20.14 ± 11.12 days in the SCS group, p = 0.001). HMP provided safe and reliable preservation in orphan livers transplanted at our center. © Copyright 2014 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  Clinical research/practice; donors and donation: extended criteria, liver allograft function/dysfunction; ischemia reperfusion injury (IRI); liver transplantation/hepatology; organ perfusion and preservation; organ procurement; organ procurement and allocation

Mesh:

Year:  2014        PMID: 25521639     DOI: 10.1111/ajt.12958

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  69 in total

1.  Declining liver graft quality threatens the future of liver transplantation in the United States.

Authors:  Eric S Orman; Maria E Mayorga; Stephanie B Wheeler; Rachel M Townsley; Hector H Toro-Diaz; Paul H Hayashi; A Sidney Barritt
Journal:  Liver Transpl       Date:  2015-08       Impact factor: 5.799

Review 2.  Bioengineering approaches to organ preservation ex vivo.

Authors:  Meghan Pinezich; Gordana Vunjak-Novakovic
Journal:  Exp Biol Med (Maywood)       Date:  2019-03-19

3.  From six thousand transaminases level to three hundred after liver transplantation: a new era seems to be open.

Authors:  Matteo Ravaioli; Vanessa De Pace; Antonio D Pinna
Journal:  Updates Surg       Date:  2017-06-09

4.  Graft Reconditioning before Liver Transplantation.

Authors:  Dieter P Hoyer; Thomas Minor
Journal:  Visc Med       Date:  2016-07-29

5.  Beating the organ clock.

Authors:  Melanie Senior
Journal:  Nat Biotechnol       Date:  2018-06-06       Impact factor: 54.908

Review 6.  Donations After Circulatory Death in Liver Transplant.

Authors:  Emre A Eren; Nicholas Latchana; Eliza Beal; Don Hayes; Bryan Whitson; Sylvester M Black
Journal:  Exp Clin Transplant       Date:  2016-10       Impact factor: 0.945

Review 7.  The dawn of liver perfusion machines.

Authors:  Danielle Detelich; James F Markmann
Journal:  Curr Opin Organ Transplant       Date:  2018-04       Impact factor: 2.640

8.  Machine perfusion versus cold storage of livers: a meta-analysis.

Authors:  Sushun Liu; Qing Pang; Jingyao Zhang; Mimi Zhai; Sinan Liu; Chang Liu
Journal:  Front Med       Date:  2016-12-23       Impact factor: 4.592

Review 9.  Perfusion machines and hepatocellular carcinoma: a good match between a marginal organ and an advanced disease?

Authors:  Davide Ghinolfi; Erion Rreka; Daniele Pezzati; Franco Filipponi; Paolo De Simone
Journal:  Transl Gastroenterol Hepatol       Date:  2017-11-07

Review 10.  Liver transplantation: Current status and challenges.

Authors:  Caroline C Jadlowiec; Timucin Taner
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.